Product Information
NEOMYCIN-POLYMYXIN-HC EAR SUSP is a generic product labeled by Bausch & Lomb Incorporated, priced at $3.7894 per ML under NDC 24208063562. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 28, 1996. Its Orange Book therapeutic-equivalence code is AT.
Strength
10; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208063562
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
8/19/2026
Active Ingredients
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064065FDA Approved
8/28/1996
TE Code
AT
On Market Since
8/28/1996
Pharmacological Classes
Price Statistics
The NADAC for NEOMYCIN-POLYMYXIN-HC EAR SUSP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 99.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7894 per ML |
|---|---|
| All-time high | $8.1994 (Jan 13, 2016) |
| All-time low | $1.8455 (Aug 19, 2015) |
| 52-week high | $4.6405 |
| 52-week low | $3.7744 |
| Median price | $5.5665 |
| Average price | $5.0433 |
| Largest weekly change | +236.1% (Sep 30, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEOMYCIN-POLYMYXIN-HC EAR SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYCIN-POLYMYXIN-HC EAR SUSP, manufactured by Bausch & Lomb Incorporated, is $3.7894 per ML (NDC 24208063562), effective Aug 19, 2026.
How has the price of NEOMYCIN-POLYMYXIN-HC EAR SUSP changed over time?
Over the history we have for it, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SUSP has risen 99.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYCIN-POLYMYXIN-HC EAR SUSP?
Since Nov 28, 2013, the NADAC for NEOMYCIN-POLYMYXIN-HC EAR SUSP has ranged from a low of $1.8455 (Aug 19, 2015) to a high of $8.1994 (Jan 13, 2016), with a median of $5.5665 per ML.
Are there cheaper alternatives to NEOMYCIN-POLYMYXIN-HC EAR SUSP?
No other NADAC-published product currently shares the active ingredient and strength of NEOMYCIN-POLYMYXIN-HC EAR SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEOMYCIN-POLYMYXIN-HC EAR SUSP?
NEOMYCIN-POLYMYXIN-HC EAR SUSP (NDC 24208063562) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.